Pages that link to "Q42826420"
Jump to navigation
Jump to search
The following pages link to Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation. (Q42826420):
Displaying 50 items.
- The Role of PPARs in Cancer (Q21342955) (← links)
- PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis (Q24553314) (← links)
- The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention (Q24601222) (← links)
- Endoplasmic reticulum stress and the inflammatory basis of metabolic disease (Q24633352) (← links)
- Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1 (Q26752511) (← links)
- Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer (Q26829126) (← links)
- Diabetes and cancer: a consensus report. (Q27686977) (← links)
- Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis (Q28070220) (← links)
- Inflammation and cellular stress: a mechanistic link between immune-mediated and metabolically driven pathologies (Q28236897) (← links)
- Omega-3 Fatty Acids and PPARgamma in Cancer (Q28292907) (← links)
- Deletion of eIF2beta suppresses testicular cancer incidence and causes recessive lethality in agouti-yellow mice (Q28592368) (← links)
- Differentiation therapy of leukemia: 3 decades of development (Q33409795) (← links)
- Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma (Q33496190) (← links)
- The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging (Q33540291) (← links)
- In vivo effects of rosiglitazone in a human neuroblastoma xenograft (Q33723620) (← links)
- PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis (Q34509964) (← links)
- Translation initiation and its deregulation during tumorigenesis (Q34601604) (← links)
- Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer (Q34646050) (← links)
- In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer (Q34667419) (← links)
- Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes (Q34718437) (← links)
- PPARgamma-regulated tight junction development during human urothelial cytodifferentiation (Q34863027) (← links)
- Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases (Q35224775) (← links)
- PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling. (Q35458969) (← links)
- Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms (Q35596926) (← links)
- Crosstalk of oncogenic and prostanoid signaling pathways (Q35810119) (← links)
- PPARγ stimulates expression of L-type amino acid and taurine transporters in human placentas: the evidence of PPARγ regulating fetal growth (Q35905696) (← links)
- Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity. (Q36068458) (← links)
- Tumor suppression by small molecule inhibitors of translation initiation. (Q36339255) (← links)
- Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases (Q36426782) (← links)
- PPAR-gamma in the Cardiovascular System (Q36426786) (← links)
- Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells (Q36611745) (← links)
- A phase II trial with rosiglitazone in liposarcoma patients (Q36671304) (← links)
- Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines (Q36695847) (← links)
- PPARgamma and MEK Interactions in Cancer (Q36737285) (← links)
- A Novel Mechanism of PPARgamma Regulation of TGFbeta1: Implication in Cancer Biology (Q36743890) (← links)
- Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells (Q36825482) (← links)
- Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target (Q36934029) (← links)
- Peroxisome proliferator-activated receptor-delta induces cell proliferation by a cyclin E1-dependent mechanism and is up-regulated in thyroid tumors (Q36983141) (← links)
- Thiazolidinediones as anti-cancer agents (Q37010188) (← links)
- PPAR gamma signaling exacerbates mammary gland tumor development (Q37092279) (← links)
- PPARgamma Inhibitors as Novel Tubulin-Targeting Agents (Q37176066) (← links)
- CD36 signaling inhibits the translation of heat shock protein 70 induced by oxidized low density lipoprotein through activation of peroxisome proliferators-activated receptor gamma (Q37184997) (← links)
- Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours (Q37188588) (← links)
- The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products (Q37211832) (← links)
- Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types (Q37263875) (← links)
- 1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes decrease mitochondrial membrane potential and induce apoptosis in endometrial and other cancer cell lines (Q37263942) (← links)
- PPARgamma-independent antitumor effects of thiazolidinediones (Q37267184) (← links)
- Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments (Q37294120) (← links)
- Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor γ (PPARγ) stability through its deubiquitinating activity. (Q37311332) (← links)
- Small-Molecule targeting of translation initiation for cancer therapy (Q37381582) (← links)